FEED Stock — ENvue Medical Inc.

ENvue Medical Inc. (FEED)

Updated October 16, 2026.

FEED is a Stock. Total return is -100.0% over the past 11.4 years, 434.1 points behind SPY at 334.1%.

ENvue Medical develops non-invasive ultrasound-based medical devices for biofilm prevention, pain management, and wound healing, sold directly to patients and through distributors across the United States, Europe, and other international markets. The company's product portfolio includes UroShield for urinary catheter management, PainShield for pain and muscle conditions, and WoundShield for tissue regeneration. The company does not currently distribute to shareholders.

FEED performance versus SPY

Price and return data through 2026-10-16.

Total return is -100.0% over the past 11.4 years, 434.1 points behind SPY at 334.1%. Over the past year its total return — price change plus distributions reinvested — is -99.5%. Its deepest 1-year drawdown was 99.7%.

FEED key facts

Asset type

Stock

Asset class

Equity

Inception date

05/28/2015

Distribution frequency

None

Last close

$0.37 (as of 2026-10-16)

Market cap

$342,791

Average volume

998.0

Beta

1.375

Payout ratio

0.0%

EPS

$-302.64

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

FEED risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 99.7%.

Who may consider FEED — and who may not

It is a weaker fit for investors who need monthly cash flow (FEED does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on FEED

• All tickers starting with F

Tagged: Healthcare.

Frequently asked questions